HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sebastiano Andò Selected Research

Type 5 Cyclic Nucleotide Phosphodiesterases

11/2019Phosphodiesterase 5 (PDE5) Is Highly Expressed in Cancer-Associated Fibroblasts and Enhances Breast Tumor Progression.
11/2017Phosphodiesterase type 5 and cancers: progress and challenges.
1/2017Effect of sildenafil on human aromatase activity: From in vitro structural analysis to catalysis and inhibition in cells.
1/2016Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sebastiano Andò Research Topics

Disease

116Breast Neoplasms (Breast Cancer)
10/2023 - 07/2002
104Neoplasms (Cancer)
10/2023 - 07/2002
26Obesity
06/2023 - 03/2009
20Carcinogenesis
05/2023 - 05/2004
13Neoplasm Metastasis (Metastasis)
01/2023 - 10/2006
6Inflammation (Inflammations)
05/2023 - 01/2020
5Triple Negative Breast Neoplasms
01/2023 - 04/2015
5Prostatic Neoplasms (Prostate Cancer)
11/2016 - 06/2004
4Glioblastoma (Glioblastoma Multiforme)
06/2023 - 01/2020
4Seminoma
01/2019 - 12/2005
4Leydig Cell Tumor
05/2012 - 08/2007
3Body Weight (Weight, Body)
01/2021 - 08/2003
3Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 12/2016
3Insulin Resistance
03/2020 - 08/2011
3Thyroid Neoplasms (Thyroid Cancer)
01/2014 - 10/2006
3Endometrial Neoplasms (Endometrial Cancer)
07/2012 - 03/2006
2Goiter
10/2023 - 10/2019
2Carcinoma (Carcinomatosis)
01/2023 - 07/2019
2Disease Progression
03/2021 - 01/2016
2Pathologic Processes
01/2021 - 01/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

44Estrogens (Estrogen)FDA Link
09/2021 - 07/2002
28Estrogen ReceptorsIBA
08/2023 - 07/2002
27Hormones (Hormone)IBA
05/2023 - 07/2002
27Proteins (Proteins, Gene)FDA Link
01/2023 - 11/2004
26Estrogen Receptor alphaIBA
01/2021 - 07/2002
23LeptinIBA
01/2023 - 08/2003
23LigandsIBA
01/2023 - 09/2005
21Aromatase (CYP19)IBA
09/2021 - 07/2002
16AdipokinesIBA
05/2023 - 11/2011
14AndrogensIBA
08/2023 - 07/2002
13TamoxifenFDA LinkGeneric
01/2021 - 03/2006
12Androgen Receptors (Androgen Receptor)IBA
08/2023 - 05/2005
12Estradiol (Delestrogen)FDA LinkGeneric
01/2021 - 07/2002
10AdiponectinIBA
05/2023 - 01/2014
10Messenger RNA (mRNA)IBA
09/2021 - 09/2007
10ElementsIBA
07/2021 - 02/2007
10CytokinesIBA
07/2021 - 04/2007
9Cyclin D1IBA
11/2019 - 03/2009
8Aromatase InhibitorsIBA
01/2022 - 07/2002
8Antineoplastic Agents (Antineoplastics)IBA
09/2020 - 05/2013
8EnzymesIBA
11/2019 - 07/2002
8G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2016 - 06/2004
8Insulin-Like Growth Factor I (IGF-1)IBA
01/2015 - 09/2007
7Conditioned Culture MediaIBA
06/2023 - 01/2016
7Leptin ReceptorsIBA
01/2021 - 11/2011
7Estrogen Receptor Modulators (Antiestrogen)IBA
01/2021 - 05/2010
7PPAR gammaIBA
10/2020 - 09/2005
6ResveratrolIBA
06/2023 - 07/2009
6Insulin (Novolin)FDA Link
01/2023 - 06/2007
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2020 - 09/2005
6Estrogen Receptor betaIBA
02/2014 - 06/2004
5Biomarkers (Surrogate Marker)IBA
10/2023 - 08/2012
5Insulin-Like PeptidesIBA
01/2019 - 07/2006
5SteroidsIBA
01/2016 - 06/2004
4MicroRNAs (MicroRNA)IBA
10/2023 - 03/2016
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2020 - 11/2013
4Therapeutic UsesIBA
09/2020 - 10/2006
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 05/2009
4Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
11/2019 - 01/2016
4Tyrosine (L-Tyrosine)FDA Link
01/2014 - 10/2009
4Epidermal Growth Factor (EGF)IBA
05/2010 - 08/2008
3Docosahexaenoic AcidsIBA
01/2023 - 06/2013
3Dehydroepiandrosterone (DHEA)IBA
01/2023 - 07/2002
3Cadherins (E-Cadherin)IBA
01/2023 - 04/2007
3Small Interfering RNA (siRNA)IBA
01/2023 - 04/2011
3Phosphotransferases (Kinase)IBA
08/2022 - 06/2009
3AntioxidantsIBA
07/2021 - 01/2016
3RetinoidsIBA
07/2021 - 01/2016
3Transcription Factors (Transcription Factor)IBA
09/2020 - 09/2007
3ChromatinIBA
11/2019 - 04/2007
3progesterone receptor BIBA
08/2019 - 11/2014
3Protein Isoforms (Isoforms)IBA
01/2019 - 06/2009
3GW 4064IBA
02/2016 - 02/2010
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2016 - 05/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016 - 10/2013
3afimoxifene (hydroxytamoxifen)IBA
05/2010 - 03/2006
3Cyclic AMP (AMP, Cyclic)IBA
03/2009 - 04/2007
3ErbB Receptors (EGF Receptor)IBA
03/2009 - 02/2007
3Carrier Proteins (Binding Protein)IBA
03/2009 - 04/2007
2IodineIBA
10/2023 - 10/2019
2Ethanolamine (Colamine)IBA
01/2023 - 06/2013
2Oxygen (Dioxygen)IBA
01/2023 - 03/2011
2ChemokinesIBA
01/2023 - 11/2019
2Lysine (L-Lysine)FDA Link
08/2022 - 06/2009
2Selective Estrogen Receptor Modulators (SERM)IBA
01/2022 - 01/2019
2PolyphenolsIBA
07/2021 - 06/2010
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
07/2021 - 06/2013
2Fulvestrant (Faslodex)FDA Link
01/2020 - 06/2004
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2019 - 01/2016
2Steroid Receptors (Steroid Receptor)IBA
11/2019 - 06/2004
2Dopamine (Intropin)FDA LinkGeneric
09/2019 - 11/2015
2Phenobarbital (Luminal)FDA Link
08/2019 - 10/2014
2Progesterone Receptors (Progesterone Receptor)IBA
08/2019 - 09/2016
2Peptides (Polypeptides)IBA
07/2019 - 05/2015
2Fas Ligand Protein (Fas Ligand)IBA
11/2017 - 02/2009

Therapy/Procedure

35Therapeutics
01/2023 - 06/2009
3Precision Medicine
10/2023 - 07/2019
2Mediterranean Diet
10/2023 - 07/2021
2Radiotherapy
01/2023 - 02/2010